ES2160089A1 - Method and device for the production of microparticles for controlled release of water-soluble pharmaceuticals and viral vectors. application to the administration of plasmid dna and defective recombinant adenovirus - Google Patents
Method and device for the production of microparticles for controlled release of water-soluble pharmaceuticals and viral vectors. application to the administration of plasmid dna and defective recombinant adenovirusInfo
- Publication number
- ES2160089A1 ES2160089A1 ES200000629A ES200000629A ES2160089A1 ES 2160089 A1 ES2160089 A1 ES 2160089A1 ES 200000629 A ES200000629 A ES 200000629A ES 200000629 A ES200000629 A ES 200000629A ES 2160089 A1 ES2160089 A1 ES 2160089A1
- Authority
- ES
- Spain
- Prior art keywords
- plasmid dna
- production
- viral vectors
- water
- recombinant adenovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The method involves obtaining a multiple emulsion by injecting immiscible liquid phases under high turbulence. The device used for said purpose, which is called TROMS or "Total Recirculation One-Machine System", comprises a pumping system (1) that is connected to a Rehodine valve (2) from which two needles (3, 4) having different inner diameters stick out. The first needle is inserted into the first mixing vessel (5) and the other needle is inserted into the second mixing vessel (6). The organic phase is introduced into the system by means of a glass syringe with a Teflon plunger (7). The mixing vessels are connected to the pump by two valves (8 and 9). The method and device used are suitable for the production of homogenous microcapsule or heterogeneous microsphere type microparticles that are suitable for the encapsulation of water-soluble pharmaceuticals including plasmid DNA, RNA, genes, oligonucleotides, peptides, proteins and viral vectors used in genic therapy and defective recombinant adenovirus.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200000629A ES2160089B1 (en) | 2000-03-15 | 2000-03-15 | PROCEDURE AND APPARATUS FOR THE PRODUCTION OF MICROPARTICLES FOR THE CONTROLLED RELEASE OF HYDROSOLUBLE DRUGS AND VIRAL VECTORS. APPLICATION TO THE ADMINISTRATION OF PLASMIDIC DNA AND DEFECTIVE RECOMBINANT ADENOVIRUS. |
AU40700/01A AU4070001A (en) | 2000-03-15 | 2001-03-15 | Method and device for the production of microparticles for controlled release of water-soluble pharmaceuticals and viral vectors. Application to the administration of plasmid DNA and defective recombinant adenovirus |
PCT/ES2001/000100 WO2001068059A1 (en) | 2000-03-15 | 2001-03-15 | Method and device for the production of microparticles for controlled release of water-soluble pharmaceuticals and viral vectors. application to the administration of plasmid dna and defective recombinant adenovirus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200000629A ES2160089B1 (en) | 2000-03-15 | 2000-03-15 | PROCEDURE AND APPARATUS FOR THE PRODUCTION OF MICROPARTICLES FOR THE CONTROLLED RELEASE OF HYDROSOLUBLE DRUGS AND VIRAL VECTORS. APPLICATION TO THE ADMINISTRATION OF PLASMIDIC DNA AND DEFECTIVE RECOMBINANT ADENOVIRUS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2160089A1 true ES2160089A1 (en) | 2001-10-16 |
ES2160089B1 ES2160089B1 (en) | 2002-05-16 |
Family
ID=8492720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200000629A Expired - Fee Related ES2160089B1 (en) | 2000-03-15 | 2000-03-15 | PROCEDURE AND APPARATUS FOR THE PRODUCTION OF MICROPARTICLES FOR THE CONTROLLED RELEASE OF HYDROSOLUBLE DRUGS AND VIRAL VECTORS. APPLICATION TO THE ADMINISTRATION OF PLASMIDIC DNA AND DEFECTIVE RECOMBINANT ADENOVIRUS. |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4070001A (en) |
ES (1) | ES2160089B1 (en) |
WO (1) | WO2001068059A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105434504B (en) * | 2014-08-29 | 2021-10-15 | 黑龙江科伦制药有限公司 | Fat emulsion tail liquid treatment device and method |
CN108770945A (en) * | 2018-05-22 | 2018-11-09 | 祖名豆制品股份有限公司 | A kind of manufacture craft and soybean protein isolate exquisiteness processing unit of bean curd |
CN111594423B (en) * | 2020-04-21 | 2021-08-17 | 通用生物系统(安徽)有限公司 | Fluid control device for gene synthesis and working method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011010A1 (en) * | 1993-10-22 | 1995-04-27 | Genentech, Inc. | Methods and compositions for microencapsulation of antigens for use as vaccines |
ES2134130A1 (en) * | 1997-02-05 | 1999-09-16 | Inst Cientifico Tecnol Navarra | Procedure and apparatus for the production of non- biological vectors for transport of substances by turbulent coaxial injection. |
WO1999053903A1 (en) * | 1998-04-23 | 1999-10-28 | The Regents Of The University Of Michigan | Microspheres containing condensed polyanionic bioactive agents and methods for their production |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2172507C (en) * | 1993-10-22 | 2008-12-02 | Jeffrey L. Cleland | Methods and compositions for microencapsulation of antigens for use as vaccines |
-
2000
- 2000-03-15 ES ES200000629A patent/ES2160089B1/en not_active Expired - Fee Related
-
2001
- 2001-03-15 AU AU40700/01A patent/AU4070001A/en not_active Abandoned
- 2001-03-15 WO PCT/ES2001/000100 patent/WO2001068059A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011010A1 (en) * | 1993-10-22 | 1995-04-27 | Genentech, Inc. | Methods and compositions for microencapsulation of antigens for use as vaccines |
ES2134130A1 (en) * | 1997-02-05 | 1999-09-16 | Inst Cientifico Tecnol Navarra | Procedure and apparatus for the production of non- biological vectors for transport of substances by turbulent coaxial injection. |
WO1999053903A1 (en) * | 1998-04-23 | 1999-10-28 | The Regents Of The University Of Michigan | Microspheres containing condensed polyanionic bioactive agents and methods for their production |
Also Published As
Publication number | Publication date |
---|---|
AU4070001A (en) | 2001-09-24 |
WO2001068059A1 (en) | 2001-09-20 |
ES2160089B1 (en) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Elvassore et al. | Production of protein-loaded polymeric microcapsules by compressed CO2 in a mixed solvent | |
RU2224538C2 (en) | Pharmaceutical compositions designated for prolonged releasing peptides and method for their preparing | |
US6361798B1 (en) | Method and apparatus for formulating microspheres and microcapsules | |
CN101400363B (en) | Pharmaceutical compositions with enhanced stability | |
CA3002871C (en) | Improvements in solid phase peptide synthesis | |
JP2004529739A (en) | Spike for liquid transfer device, liquid transfer device having spike, and liquid transfer method using the same | |
CN106999653A (en) | Wearable automatic injection system and equipment | |
Deng et al. | Compound‐droplet‐pairs‐filled hydrogel microfiber for electric‐field‐induced selective release | |
ES2878186T3 (en) | Process to produce polymeric microspheres | |
ES2160089A1 (en) | Method and device for the production of microparticles for controlled release of water-soluble pharmaceuticals and viral vectors. application to the administration of plasmid dna and defective recombinant adenovirus | |
Calnan et al. | Potency and stability of C terminal truncated human epidermal growth factor | |
SK7172003A3 (en) | Microparticles with an improved release profile and method for the production thereof | |
CN212417796U (en) | A emulsification equipment for preparing liposome medicine | |
CN103932989A (en) | Method used for preparing pharmaceutic adjuvant Eudragit RL100 polymer particulates | |
CN211284347U (en) | Efficient multi-liquid-medicine liquid injection device and chromosome harvesting and processing system thereof | |
Han et al. | Preparation of long-acting microspheres loaded with octreotide for the treatment of portal hypertensive | |
CN116234567A (en) | Method for assembling two-component virus-like particles | |
JP2020110606A (en) | Needle-free subcutaneous application of proteins | |
LU101974B1 (en) | Process and apparatus for preparing viscous pharmaceutical formulations | |
CN104208040A (en) | Method for preparing medicinal auxiliary Eudragit S100 polymer particle | |
US20240109066A1 (en) | Microfluidic mixing and/or separater | |
Agrawal et al. | Parenteral delivery of peptides and proteins | |
EP4192427A1 (en) | Process and apparatus for preparing viscous pharmaceutical formulations | |
CN103800282B (en) | Breviscapine nose microemulsion gel preparation and preparation method thereof | |
CN217908365U (en) | Continuous production system of triptorelin sustained-release preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20011016 Kind code of ref document: A1 Effective date: 20011016 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20180807 |